Surmodics completes $43/share merger with BCE Parent, goes private

Surmodics completed its merger with BCE Parent, LLC on November 19, 2025, with shareholders receiving $43.00 per share in cash. The company will delist from Nasdaq and become a private subsidiary.

“Surmodics, Inc. (SRDX) completed its previously announced merger with BCE Parent, LLC on November 19, 2025, with Surmodics becoming a wholly owned subsidiary of Parent.”stocktitan.net

• 1 source
• stocktitan.netSurmodics (SRDX) completes $43 cash merger, to delist from Nasdaq | SRDX 8-K FilingStock TitanNov 19, 2025

Summarized from public sources; check the original articles before acting on it.